Fig. 4From: Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetesQPCR and NanoString arrays in matching PBC samples processed using the PAXgene and Tempus system. The expression of lymphocyte-signature genes (COX6C, COX7B, LSM3, RPS24, and RPL31), and genes previously shown to be changed in T1D or at-risk patients (COX6C, COX7B, LSM3, RPS24, RPL31, COMMD6, SUB1, and UQCRB; see Fig. 2) were measured by QPCR and/or NanoString arrays (a-h). Microarray, QPCR and/or NanoString arrays gave similar results, and NanoString array data showed the least amount of variation between samples. *PÂ <Â 0.05; **PÂ <Â 0.005 in PAXgene vs. Tempus-processed samples, two-tailed Wilcoxon matched-pairs signed rank testBack to article page